University of Salamanca

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 1218-01-01

Employees: 1K

Market Cap: -

Website: http://www.usal.es

Clinical Trials

Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients

Not Applicable

Recruiting

Conditions: Breast Neoplasm Malignant Primary
Focus of Study: Chemotherapy-induced Madarosis
Secondary Focus: Quality of Live in Breast Cancer Patient
Intervention: Supraorbital Cryotherapy

First Posted Date: 2025-05-02

Last Posted Date: 2025-05-02

Lead Sponsor: University of Salamanca

Target Recruit Count: 120

Registration Number: NCT06955702

Locations: 🇪🇸
Hospital Universitario de Salamanca, Salamanca, Spain
🇪🇸
Hospital Marqués de Valdecilla, Santander, Spain

Dexamethasone Treatment for Patients Undergoing Endodontics

Phase 4

Completed

Conditions: Endodontic Treatment
Pulp Necrosis
Periapical Lesions
Postoperative Pain

Interventions: Drug: Dexamethasone 4 mg
Drug: Ibuprofen group

First Posted Date: 2025-04-02

Last Posted Date: 2025-04-04

Lead Sponsor: University of Salamanca

Target Recruit Count: 82

Registration Number: NCT06906315

Locations: 🇪🇸
University of Salamanca, Salamanca, Spain

Effectiveness of Different Types of Training in Older Adults With Sarcopenic Obesity

Not Applicable

Completed

Conditions: Sarcopenic Obesity
Obesity and Overweight
Sarcopenia

First Posted Date: 2025-03-26

Last Posted Date: 2025-03-30

Lead Sponsor: University of Salamanca

Target Recruit Count: 33

Registration Number: NCT06895122

Locations: 🇪🇸
University of Salamanca, Salamanca, Spain

Psychoeducational Intervention Against Support Groups for Caregivers

Not Applicable

Completed

Conditions: Dementia

First Posted Date: 2025-03-11

Last Posted Date: 2025-03-11

Lead Sponsor: University of Salamanca

Target Recruit Count: 35

Registration Number: NCT06870474

Locations: 🇪🇸
Faculty of Psychology, University of Salamanca, Salamanca, Castilla y León, Spain

Impact of NMES, Aerobic, and Resistance Exercise on Glycemic Control in Older Adults With Type 2 Diabetes

Not Applicable

Not yet recruiting

Conditions: Type 2 Diabetes Mellitus (T2DM)

First Posted Date: 2025-03-04

Last Posted Date: 2025-04-03

Lead Sponsor: Carlos Tavares

Target Recruit Count: 105

Registration Number: NCT06856720

Topical Metronidazole vs Control in Reducing Periodontal Pockets in a Split Mouth Clinical Trial

Phase 4

Completed

Conditions: Periodontal Disease
Periodontal Inflammation

Interventions: Procedure: Root scaling
Drug: Topical Gel

First Posted Date: 2025-02-20

Last Posted Date: 2025-02-20

Lead Sponsor: University of Salamanca

Target Recruit Count: 20

Registration Number: NCT06836401

Locations: 🇪🇸
Dental School of the Faculty of Medicine, Salamanca, Spain

Impact of Twin Block and Motion Class II Appliances on Hyoid Bone Position - A Retrospective Clinical Study

Completed

Conditions: Hyoid Bone

First Posted Date: 2024-12-04

Last Posted Date: 2024-12-04

Lead Sponsor: University of Salamanca

Target Recruit Count: 82

Registration Number: NCT06715774

Locations: 🇪🇸
University of Salamanca, Salamanca, Spain

Effectiveness Of The Application Of Percutaneous Electrolysis On Muscular Scar Tissue.

Not Applicable

Active, not recruiting

Conditions: Muscle Injury
Fibrosis

First Posted Date: 2024-12-03

Last Posted Date: 2024-12-03

Lead Sponsor: University of Salamanca

Target Recruit Count: 50

Registration Number: NCT06713200

Locations: 🇪🇸
Universidad de Salamanca, Salamanca, Spain

Effects of Cognitive Training on Chemotherapy-Induced Cognitive Impairment in Colon Cancer Patients Undergoing Treatment(Chemobrain) in Oncology Patients With Colon Cancer Undergoing Active Treatment

Not Applicable

Not yet recruiting

Conditions: Oncology
Cancer-related Cognitive Impairment
Cognitive Training
Everyday Cognition
Clinical Trials
Colon Cancer

First Posted Date: 2024-11-28

Last Posted Date: 2024-11-28

Lead Sponsor: University of Salamanca

Target Recruit Count: 50

Registration Number: NCT06710639

Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment

Not Applicable

Not yet recruiting

Conditions: Cancer-related Cognitive Impairment
Oncology
Breast Cancer
Cognitive Training
Everyday Cognition
Clinical Trials

First Posted Date: 2024-11-13

Last Posted Date: 2024-11-13

Lead Sponsor: University of Salamanca

Target Recruit Count: 50

Registration Number: NCT06686823

Home Terms & Conditions Privacy Policy